48 related articles for article (PubMed ID: 18336003)
1. Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden.
Ren AH; Prassas I; Soosaipillai A; Jarvi S; Gallinger S; Kulasingam V; Diamandis EP
F1000Res; 2020; 9():732. PubMed ID: 33274048
[No Abstract] [Full Text] [Related]
2. Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models.
Shi Z; Mao B; Chen X; Hao P; Guo S
Cancer Res Commun; 2023 Feb; 3(2):202-214. PubMed ID: 36968139
[TBL] [Abstract][Full Text] [Related]
3. IRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American Women.
Yeyeodu ST; Kidd LR; Oprea-Ilies GM; Burns BG; Vancleave TT; Shim JY; Kimbro KS
Front Immunol; 2013; 4():338. PubMed ID: 24194738
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis of human lung tumor xenografts treated with the ectopic ATP synthase inhibitor citreoviridin.
Wu YH; Hu CW; Chien CW; Chen YJ; Huang HC; Juan HF
PLoS One; 2013; 8(8):e70642. PubMed ID: 23990911
[TBL] [Abstract][Full Text] [Related]
5. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
Zhang EY; Cristofanilli M; Robertson F; Reuben JM; Mu Z; Beavis RC; Im H; Snyder M; Hofree M; Ideker T; Omenn GS; Fanayan S; Jeong SK; Paik YK; Zhang AF; Wu SL; Hancock WS
J Proteome Res; 2013 Jun; 12(6):2805-17. PubMed ID: 23647160
[TBL] [Abstract][Full Text] [Related]
6. Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study.
Henkel AW; Müller K; Lewczuk P; Müller T; Marcus K; Kornhuber J; Wiltfang J
J Neural Transm (Vienna); 2012 Jul; 119(7):779-88. PubMed ID: 22415063
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteomics-based identification of cancer biomarkers.
Kim EH; Misek DE
Int J Proteomics; 2011; 2011():601937. PubMed ID: 22084691
[TBL] [Abstract][Full Text] [Related]
8. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.
Tang HY; Beer LA; Chang-Wong T; Hammond R; Gimotty P; Coukos G; Speicher DW
J Proteome Res; 2012 Feb; 11(2):678-91. PubMed ID: 22032327
[TBL] [Abstract][Full Text] [Related]
9. Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
Dai L; Liu Y; He J; Flack CG; Talsma CE; Crowley JG; Muraszko KM; Fan X; Lubman DM
Proteomics; 2011 Oct; 11(20):4021-8. PubMed ID: 21898824
[TBL] [Abstract][Full Text] [Related]
10. Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.
Abbott DE; Margaryan NV; Jeruss JS; Khan S; Kaklamani V; Winchester DJ; Hansen N; Rademaker A; Khalkhali-Ellis Z; Hendrix MJ
Cancer Biol Ther; 2010 Jan; 9(1):23-30. PubMed ID: 19923884
[TBL] [Abstract][Full Text] [Related]
11. Glycoproteomic analysis of embryonic stem cells: identification of potential glycobiomarkers using lectin affinity chromatography of glycopeptides.
Alvarez-Manilla G; Warren NL; Atwood J; Orlando R; Dalton S; Pierce M
J Proteome Res; 2010 May; 9(5):2062-75. PubMed ID: 19545112
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
[TBL] [Abstract][Full Text] [Related]
13. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
[TBL] [Abstract][Full Text] [Related]
14. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
15. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
16. [Novel tumor marker discovery of gastrointestinal cancers using various proteomic approaches].
Tomonaga T; Nomura F
Rinsho Byori; 2007 Jan; 55(1):63-8. PubMed ID: 17319493
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of proteomics in the early detection of breast cancer.
Pawlik TM; Kuerer HM
Int J Fertil Womens Med; 2005; 50(5 Pt 1):212-6. PubMed ID: 16468471
[TBL] [Abstract][Full Text] [Related]
18. A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.
Orazine CI; Hincapie M; Hancock WS; Hattersley M; Hanke JH
J Proteome Res; 2008 Apr; 7(4):1542-54. PubMed ID: 18336003
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
